ストックスクリーナーアプリを入手
212.22
2.26%
-4.90
アフターアワーズ：
212.22
Labcorp Holdings Inc (LH) 最新ニュース
Drug Abuse Testing Market Forecast Report and Company Analysis 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad Labs, Medtronic - Yahoo Finance
Drug Screening Market Size Worth USD 10.34 Billion by 2034 | CAGR of 4.84% from 2025 to 2034 - GlobeNewswire Inc.
Labcorp Holdings: Regaining Credibility - Seeking Alpha
Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Labcorp Q1 Earnings Preview: Diagnostics Arm Likely to Drive Growth - Yahoo Finance
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. - marketscreener.com
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - simplywall.st
Truist Adjusts Labcorp (LH) Price Target Ahead of Q1 Results | L - GuruFocus
Labcorp Declares Quarterly Dividend - Eastern Progress
What You Need to Know Ahead of Labcorp Holdings' Earnings Release - MSN
Truist Securities Lowers Labcorp Price Target to $274 From $285, Maintains Buy Rating - MarketScreener
Baird Adjusts Price Target on Labcorp Holdings to $253 From $292, Keeps Outperform Rating - marketscreener.com
What You Need To Know Ahead Of Labcorp Holdings' Earnings Release - Barchart.com
Labcorp Holdings Inc. (LH) Declares Cash Dividend for Shareholders - GuruFocus
Labcorp (LH) Maintains Quarterly Dividend, Offers 1.25% Yield - GuruFocus
Labcorp Declares Quarterly Dividend | LH Stock News - GuruFocus
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Barclays Adjusts Labcorp Holdings' Price Target to $240 From $260 - MarketScreener
Labcorp Keeps Quarterly Dividend at $0.72 a Share, Payable June 11 to Shareholders of Record as of May 29 - marketscreener.com
Labcorp Holdings Declares Cash Dividend for Shareholders - TipRanks
Full Fed. Circ. Lets Stand Patent Tied To $400M Labcorp Loss - Law360
Evercore ISI Adjusts Price Target on Labcorp Holdings to $260 From $275, Maintains Outperform Rating - MarketScreener
Is it the Right Time to Retain Labcorp Stock in Your Portfolio? - Yahoo Finance
Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.
Labcorp launches blood test to accelerate Alzheimer’s diagnosis - Yahoo Finance
Here's Why Labcorp (LH) is a Strong Growth Stock - Yahoo Finance
Assessing Labcorp Hldgs: Insights From 8 Financial Analysts - Benzinga
Labcorp Launches New Blood Test to Diagnose Alzheimer's Disease - MarketScreener
LH Stock to Gain From Launch of HPV and STI Self-Collection Options - TradingView
Labcorp Launches First-of-its-Kind Immunoassay to Accelerate Path to Diagnosis of Alzheimer's Disease - Financial Times
Redburn Atlantic Initiates Labcorp Holdings at Buy With $276 Price Target - MarketScreener
Esoteric Testing Market Deep Research 2025-2032 | LabCorp, Quest Diagnostics, OPKO Health, Miraca Holdings - openPR.com
Labcorp Launches First-Of-Its-Kind Immunoassay To Accelerate Path To Diagnosis Of Alzheimer's Disease - MarketScreener
Labcorp Holdings (NYSE:LH) Introduces FDA-Approved Self-Collection Tests For HPV And STIs - simplywall.st
Labcorp to Announce First Quarter Financial Results on April 29, 2025 - Eastern Progress
Labcorp to offer HPV and STI self-collection solutions - TipRanks
Game-Changing HPV Testing: Labcorp Rolls Out Private Self-Collection Options Nationwide - Stock Titan
Labcorp Holdings to Announce Q1 2025 Financial Results - TipRanks
Labcorp holdings EVP Amy Summy sells $175,605 in stock By Investing.com - Investing.com Canada
LabCorp EVP Mark Schroeder sells $610,450 in stock By Investing.com - Investing.com South Africa
Labcorp holdings EVP Amy Summy sells $175,605 in stock - Investing.com
LabCorp EVP Mark Schroeder sells $610,450 in stock - Investing.com
Baird Adjusts Labcorp Holdings Price Target to $292 From $293, Maintains Outperform Rating - MarketScreener
3.95%
大文字化:
|
ボリューム (24 時間):